Our Journey - Frequasense

Our JourneyOur Journey to Market Launch

2012

£100K TSB Grant

/ Feasibility study to test miniaturisation.
2015

Investments Received

/ £150K Angel Investment / £120 IUK SMART / £132K Director Investment / Development & testing of optical device.
2016

£100K SBRI

/ End user feasibility feedback & testing.
2017

£150K NIHR i4i Connect

/ Further development & testing / Next level development higher TRL and data.
2020

New Company Formed

/ £75K COVID Grant / Using same device to test COVID samples with new parameters.
2022

Investments Received

/ £80K application to High Growth Innovation Fund call / £400K IUK SMART / £175K Liverpool Ventures
2022

Product Developments

/ Optimising & testing higher TRL device with early data / New hand-held versions with new electronics and sensors.
2022

Total Investments Raised to Date

£1.4M

The right partnerships are critical to our success, and we are looking to engage future partners now.

Hospitals

We are seeking hospitals to work with us for multi-centered clinical trials.

Manufacturers

We are seeking partners to help us scale up manufacturing.

Diagnostic Companies

Partners operating in the diagnostic and partner diagnostic sectors.